Stephen Mitchener Insider Profile
4 Followers
Stephen Mitchener, SVP, Chief Business Officer at Karyopharm Therapeutics, holds 128.31K shares in Karyopharm Therapeutics (Ticker: KPTIQ), holds ― shares in Axcella Health (Ticker: AXLA).
Stephen Mitchener's Trading History
| KPTIQKaryopharm Therapeutics | Mar 02, 2023 | SVP, Chief Business Officer | Uninformative Buy | ― | $3.21K | |
| AXLAAxcella Health | ― | ― | ― | ― |
You May Also Like
Stephen Mitchener insider profile FAQ
What is the percentage of profitable transactions made by Stephen Mitchener?
The percentage of profitable transactions made by Stephen Mitchener is 100%.
What is the average return per transaction made by Stephen Mitchener?
The average return per transaction made by Stephen Mitchener is 46.90%.
What stocks does Stephen Mitchener hold?
Stephen Mitchener holds: KPTIQ, AXLA stocks.
What was Stephen Mitchener's most profitable transaction?
Stephen Mitchener’s most profitable transaction was an Informative Sell of KPTIQ stock on March 2, 2023. The return on the trade was 61.50%.
What is Stephen Mitchener's role in Karyopharm Therapeutics?
Stephen Mitchener's role in Karyopharm Therapeutics is SVP, Chief Business Officer.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.
TipRanks measures corporate insiders by the stock transactions they report to the SEC. See how TipRanks ranks experts and calculates performance.
